explore -WSS

explore

author：fashion 2025-10-01 23:02:03 - browse：97

Joe Biden in 2016. -- first opinion coverage from STAT — President Joe Biden Elise Amendola/AP

WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few questions on how Congress might move forward with the program.

Since its launch in 2016, the federally funded cancer moonshot program has spurred thousands of scientific publications, 49 clinical trials, and more than 30 patent filings, according to a new report from the Congressional Research Service, the nonpartisan research arm of Congress.

The next phase of the cancer moonshot, according to Biden and his administration, is meant to emphasize cancer screening, prevention, and equitable treatment. The updated plan also seeks to speed progress on treatments for rare and childhood cancers, and it calls for supporting patients, survivors, and caregivers. The Advanced Research Projects Agency for Health (ARPA-H), a new agency tasked with taking big risks on biomedical and health technology, is also committing $240 million to cancer-related research and investing in new data-sharing platforms and a nationwide network for clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

WSS

CMS got Medicare Advantage quality rating wrong, judge rules

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Alabama hospital puts IVF treatments on hold

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Antivenom research: Lessons from HIV applied in search for universal antidote

FTC loses bid to block Novant's North Carolina hospital merger

explore

explore

focus

Cancer drug shortages should be causing more outrage

Take antibiotics after sex, CDC recommends for certain risk groups

Moonlake's readout produced a cash windfall. Risks remain

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Continuity nursing helped my family in our darkest PICU moments

New documents shed light on MD Anderson Cancer Institute feud

As demand for Covid shots wanes, Moderna seeks its next success

Structure Therapeutics oral GLP

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

hotspot

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Senators tussle over abortion against the backdrop of a presidential campaign

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

6 phony surgeries that take placebo to the extreme

STAT wants to know your pick for a great summer read or listen

explore

knowledge

hotspot

hotspot